Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diphenylacetylene SCHEMBL29188592 | 0.77 | APP (1.00) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL960609 | 0.77 | APP (1.00) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL68254 | 0.77 | APP (1.00) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8013823 | 0.76 | APP (0.52) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL23754282 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL9273707 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL31243352 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL5576302 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL31286315 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 | |
| Diphenylacetylene SCHEMBL28768551 | 0.74 | APP (0.92) | APPMAPTCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10266409-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2019-04-23 | — | — | US | claimed |
| EP-4652173-A1 | METHOD FOR THE GENERATION OF A HEXAFLUOROPHOSPHATE OR A PHOSPHORUS-COMPRISING ORGANIC COMPOUND | Universität Regensburg, in Vertretung des Freistaats Bayern (DE) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024153658-A1 | METHOD FOR THE GENERATION OF A HEXAFLUOROPHOSPHATE OR A PHOSPHORUS-COMPRISING ORGANIC COMPOUND | UNIVERSITÄT REGENSBURG (DE) | 2024-07-25 | — | — | WO | disclosed |
| US-10266409-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-10029972-B2 | Use of heteroleptic indium hydroxides as precursors for INP nanocrystals | NANOSYS, INC. (US) | 2018-07-24 | — | — | US | disclosed |
| US-9884763-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-9688534-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170137360-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | SHOEI CHEMICAL INC. (JP) | 2017-05-18 | — | — | US | disclosed |
| WO-2017083483-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | NANOSYS, INC. (US) | 2017-05-18 | — | — | WO | disclosed |
| US-9469538-B1 | Process for group III-IV semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2016-10-18 | — | — | US | disclosed |
| US-8884273-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-8062967-B1 | Process for group III-V semiconductor nanostructure synthesis and compositions made using same | NANOSYS, INC. (US) | 2011-11-22 | — | — | US | disclosed |
| US-7557028-B1 | For example, making indium phosphide (InP)semiconductors starting from tribenzoyl phosphine and tris-cyclopentadienyl indium; use in photovoltaic devices and light emitting diodes | NANOSYS, INC. (US) | 2009-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10029972-B2 | Use of heteroleptic indium hydroxides as precursors for INP nanocrystals | INPP5A, INPP5B, INPPL1 | APP 2093/4885MAPT 2560/4885CYP1A2 1084/4885 |
| US-20170137360-A1 | USE OF HETEROLEPTIC INDIUM HYDROXIDES AS PRECURSORS FOR INP NANOCRYSTALS | INPP5A, INPP5B, INPPL1 | APP 2093/4885MAPT 2560/4885CYP1A2 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.